Adjuvant Pembrolizumab (NSCLC), Elacestrant, & Pirtobrutinib
OncoPharm
00:00
Practical Notes on Elacestrant Administration
John comments on food effect, label guidance to take with food, and monitoring for dyslipidemia and drug interactions.
Play episode from 13:04
Transcript
